All news

Bone-targeting agents were 2011's top story

Added: Wednesday 1 February 2012

Dr Lee Schwartzberg argues that bone-targeting agents were the most important development of 2011 for supportive car oncology. Because bone is a very common metastatic site for various different types of cancers, bone health is an important research area. He praises the use of denosumab in patients receiving hormonal deprivation therapy (which can lead to bone loss).


+  http://www.oncologystat.com/viewpoints/interviews/Dr_Lee_Schwartzberg_Bone_Targeted_Agents_Were_Last_Years_top_Story_in_Supportive_Care.html;jsessionid=C8740D0116A7EFD36102351626DB4B9D


//